|
|
|
|
|
|
|
||
Article |
Proximal, selective, and dynamic interactions between integrin 
IIbß3 and protein tyrosine kinases in living cells
Address correspondence to S.J. Shattil, Department of Cell Biology, The Scripps Research Institute, 10550 North Torrey Pines Rd., VB-5, La Jolla, CA 92037. Tel.: (858) 784-7148. Fax: (858) 784-7422. email: shattil{at}scripps.edu
 |
Abstract |
|---|
 Top Abstract IntroductionResults and discussionMaterials and methodsReferences |
|---|
Stable platelet aggregation, adhesion, and spreading during hemostasis are promoted by outside-in
IIbß3 signals that feature rapid activation of c-Src and Syk, delayed activation of FAK, and cytoskeletal reorganization. To evaluate these IIbß3–tyrosine kinase interactions at nanometer proximity in living cells, we monitored bioluminescence resonance energy transfer between GFP and Renilla luciferase chimeras and bimolecular fluorescence complementation between YFP half-molecule chimeras. These techniques revealed that IIbß3 interacts with c-Src at the periphery of nonadherent CHO cells. After plating cells on fibrinogen, complexes of IIbß3–c-Src, IIbß3–Syk, and c-Src–Syk are observed in membrane ruffles and focal complexes, and the interactions involving Syk require Src activity. In contrast, FAK interacts with IIbß3 and c-Src, but not with Syk, in focal complexes and adhesions. All of these interactions require the integrin ß3 cytoplasmic tail. Thus, IIbß3 interacts proximally, if not directly, with tyrosine kinases in a coordinated, selective, and dynamic manner during sequential phases of IIbß3 signaling to the actin cytoskeleton.
Key Words: signaling; Src; Syk; FAK; bioluminescence
Abbreviations used in this paper: BiFC, bimolecular fluorescence complementation; BRET, bioluminescence resonance energy transfer; BSA, bovine serum albumin; Rluc, Renilla luciferase.
|
Introduction |
|---|
|
TopAbstractIntroductionResults and discussionMaterials and methodsReferences |
|---|
IIbß3 triggers signals that promote cytoskeletal reorganization, spreading, and aggregation (Shattil et al., 1998). Prominent biochemical events during this process include activation of the tyrosine kinases Src, Syk, FAK, and Btk and tyrosine phosphorylation of proteins in integrin-based adhesion sites (Lipfert et al., 1992; Mukhopadhyay et al., 2001; Obergfell et al., 2002). Unlike activation of FAK or Btk, activation of Src and Syk is relatively rapid and independent of actin polymerization (Clark et al., 1994; Obergfell et al., 2002). Genetic ablation or pharmacological inhibition of Src or Syk impairs platelet spreading and FAK activation, indicating that these responses are dependent on integrin activation of Src and Syk (Obergfell et al., 2002).
The molecular basis for IIbß3 activation of tyrosine kinases is incompletely understood. c-Src and several other Src family kinases coimmunoprecipitate with IIbß3 from resting platelets. In contrast, Syk coimmunoprecipitates with IIbß3 only after platelet adhesion to fibrinogen (Obergfell et al., 2002). Work in CHO cells indicates that c-Src and Syk activation requires IIbß3 clustering and an intact ß3 cytoplasmic tail (Hato et al., 1998; Arias-Salgado et al., 2003). Because c-Src, Syk, and FAK can bind directly to ß3 tail peptides or model ß3 tail proteins in vitro (Schaller et al., 1995; Woodside et al., 2002; Arias-Salgado et al., 2003), direct interactions between ß3 and tyrosine kinases may promote outside-in signaling.
To better define IIbß3–tyrosine kinase interactions in living cells, we have used two protein interaction reporter assays that can detect proximal (nm) interactions, bioluminescence resonance energy transfer (BRET), and bimolecular fluorescence complementation (BiFC). BRET between a Renilla luciferase (Rluc) chimera and another chimera with a luminescence acceptor, such as GFP, has been used to study homooligomerization of receptors, including integrins, by luminometry (Angers et al., 2000; Boute et al., 2002; Ramsay et al., 2002; Buensuceso et al., 2003). In BiFC, two potential interacting proteins are fused to NH2- and COOH-terminal half-molecules of YFP, respectively. If the transfected proteins interact, YFP may be reconstituted (Hu et al., 2002; Hu and Kerppola, 2003). Thus, BiFC may complement information derived from BRET by enabling visualization and subcellular localization of IIbß3–tyrosine kinase complexes by fluorescence microscopy. Both techniques require expression of chimeric proteins, but they have the potential to supplement biochemical and genetic analyses of integrins. Using BRET, BiFC, and proteins fused to suitable reporters, we establish here that proximal IIbß3–tyrosine kinase interactions occur in a coordinated and sequential manner within membrane ruffles and specific adhesion structures, providing a spatial context for outside-in IIbß3 signaling.
|
Results and discussion |
|---|
|
TopAbstractIntroductionResults and discussionMaterials and methodsReferences |
|---|
IIbß3 and c-Src in living cellsIIbß3, CHO cells were transfected with ß3 and chimeras of IIb and c-Src that contain reporter groups for BRET or BiFC (Figs. 1 A and 2 A). CHO cells were used because they recapitulate outside-in IIbß3 signaling responses characteristic of platelets (Miranti et al., 1998; Obergfell et al., 2001). Preliminary studies with a ligand-mimetic antibody indicated that each IIbß3 chimera was surface expressed in a default low-affinity state, similar to wild-type IIbß3. Furthermore, as in platelets (Obergfell et al., 2002), c-Src and Syk chimeras became activated upon CHO cell adhesion to fibrinogen, and they coimmunoprecipitated with IIbß3.
|
80 nm of each other and in a favorable orientation, enabling nonradiative energy transfer between an Rluc substrate (coelenterazine) and GFP. When cells in suspension expressing IIbRlucß3 and either c-Src or c-SrcGFP were compared, the c-SrcGFP–expressing cells exhibited a 27.1% increase in BRET ratio (P < 0.01; Fig. 1 B). BRET was not affected by cell adhesion to fibrinogen (unpublished data). Minimal, nonsignificant BRET increases were observed if GFP was expressed instead of SrcGFP, or if IIbRluc was coexpressed with ß3
724, which lacks most of the ß3 cytoplasmic tail (Fig. 1 B). Because the ß3 tail interacts directly with c-Src in vitro (Arias-Salgado et al., 2003), these results are consistent with a similar direct, constitutive interaction between IIbß3 and c-Src in cells.
BiFC was performed by fusing IIb to the COOH-terminal half-molecule of YFP (IIbYC) and c-Src to the NH2-terminal half of YFP (SrcYN; Fig. 2 A). BiFC between IIbYCß3 and SrcYN was observed around the periphery of nonadherent cells and at the ruffling edges of lamellipodia of fibrinogen-adherent cells, where it colocalized with antibody-labeled IIbß3 and c-Src (Fig. 2 B, i). In contrast, no BiFC was observed in cells expressing ß3724 (Fig. 2 B, ii). BiFC between IIbYCß3 and SrcYN also colocalized with cortactin within a distance of 3–4 µm from the leading edge (Fig. 2 C, i), and with vinculin and F-actin in small focal complexes and larger focal adhesions (Fig. 2 C, ii). Similarly, when unfixed cells were analyzed by real-time fluorescence microscopy, BiFC between IIbYCß3 and SrcYN was detected within membrane ruffles, focal complexes, and focal adhesions (Fig. 3 A and Video 1, available at http://www.jcb.org/cgi/content/full/jcb.200402064/DC1). Over a 6-min observation period, IIbYCß3–SrcYN complexes appeared to move from membrane ruffles to the focal adhesion structures, a conclusion supported by the predominant colocalization of the BiFC signal with known markers of these structures in fixed and stained cells (Fig. 2 C). Thus, the proximity of IIbß3 to c-Src and the dynamic nature of IIbß3–c-Src complexes upon integrin ligation provide a spatial context for initiation of outside-in IIbß3 signaling. Similarly, interaction between c-Src and the related integrin, Vß3, may occur within podosomes of osteoclasts (Linder and Aepfelbacher, 2003), whereas the absence of such an interaction may help to explain the overlapping bone resorbtion defects in mice deficient in either Vß3 or c-Src (Soriano et al., 1991; McHugh et al., 2000).
|
|
IIbß3 and c-Src, but not with FAK, in living cellsIIbß3 and c-Src (Obergfell et al., 2002). Consistent with this finding, an increase in BRET ratio between SykRluc and SrcGFP was observed when IIbß3-CHO cells were plated on fibrinogen and compared with suspension cells (P < 0.01). No such increase occurred if ß3724 was expressed instead of ß3 (Fig. 4 A). Thus, IIbß3 ligation induces a proximal interaction between Syk and c-Src. Interactions between IIbß3, Syk, and c-Src were examined in more detail by BiFC using the chimeras shown in Fig. 2 A. Both Syk–c-Src and IIbß3–Syk BiFC complexes were detectable in fibrinogen-adherent cells but not in cells maintained in suspension. The results for the SykYC/SrcYN combination are illustrated in Fig. 4 (B and C). BiFC complexes involving Syk required an intact ß3 cytoplasmic tail (Fig. 4 B), and they were present in membrane ruffles and lamellipodia, where they colocalized with cortactin, and in small focal complexes, where they colocalized with IIbß3 and vinculin (Fig. 4 C). However, BiFC complexes containing Syk were not detected in larger focal adhesions, which were identified by staining for vinculin and F-actin (Fig. 4 C, ii).
|
IIbß3 were dynamic, moving over an observation period of 6 min from membrane ruffles to small structures close to the cell periphery that resembled focal complexes. Thus, in contrast to IIbß3–c-Src complexes, which are constitutive and present at sites ranging from ruffles to mature focal adhesions, complexes involving Syk are induced by cell adhesion and confined primarily to ruffles and nascent adhesion structures close to the cell periphery. Like c-Src, Syk can bind directly to the ß3 cytoplasmic tail in vitro (Woodside et al., 2001; Arias-Salgado et al., 2003), providing a potential structural explanation for these results. The reporter groups used here for BRET and BiFC were fused to the IIb tail, not the ß3 tail. However, because there are likely to be direct interactions between the IIb and ß3 tails (Vinogradova et al., 2002; Kim et al., 2003), the reporter on IIb is presumably in sufficient proximity to the complementary reporter on c-Src or Syk (bound to ß3) to enable these interactions to be detected in cells by BiFC or BRET.
These results raise additional questions. First, previous work with fibrinogen-adherent platelets and IIbß3-CHO cells has shown that Src activity promotes Syk activation (Gao et al., 1997; Obergfell et al., 2002). To determine if Src activity is required to recruit Syk to IIbß3, BiFC experiments were performed in the presence of a Src kinase inhibitor, either PP2 or SU6656 (Hanke et al., 1996; Blake et al., 2000). When 5 µM PP2 or 2 µM SU6656 was added to cells before plating on fibrinogen, interactions between IIbYCß3 and SykYN were partially inhibited, whereas the inactive congener PP3 had no effect (Fig. 5 A). Similarly, PP2 or SU6656 inhibited interactions between SykYC and SrcYN. When PP2 was added to cells already adherent to fibrinogen, it caused a rapid loss of BiFC signals between IIbYCß3 and SykYN or between SykYC and c-SrcYN (unpublished data). Thus, Src activity is required for the recruitment of Syk to IIbß3 and possibly for the maintenance of a critical density of integrin–Syk complexes in adherent cells.
|
IIbYCß3 (Fig. 2 A). In fibrinogen-adherent cells, BiFC was observed between FAKYN and IIbYCß3 and between FAKYN and SrcYC in focal complexes and focal adhesions (Fig. 5 B). However, FAK complexes were not detected in membrane ruffles, and interactions between FAKYN and SykYC were not detected anywhere. Thus, IIbß3 interactions with c-Src and Syk predominate in nascent adhesion structures, whereas those with c-Src and FAK predominate in focal adhesions. These relationships may help to explain previous biochemical and genetic data in platelets that implicate c-Src and Syk in initiating filopodia formation and actin polymerization, and FAK in later responses to adhesion (Lipfert et al., 1992; Clark and Brugge, 1993; Clark et al., 1994; Obergfell et al., 2002).
The current results serve to further emphasize the dynamic and heterogeneous nature of integrin-based signaling complexes (Miyamoto et al., 1995; Zamir and Geiger, 2001), and they reveal a new level of complexity in IIbß3 signaling. On a broader level, BRET and BiFC should provide a facile means to monitor binary interactions between integrins and many other proteins. Along with FRET and other recent elegant innovations in imaging (Kraynov et al., 2000; Webb et al., 2003), these two approaches should complement biochemical and genetic investigations into the molecular basis of integrin signaling.
|
Materials and methods |
|---|
|
TopAbstractIntroductionResults and discussionMaterials and methodsReferences |
|---|
IIbß3, Syk, and FAK were obtained from M. Ginsberg (The Scripps Research Institute, La Jolla, CA; Miranti et al., 1998; Obergfell et al., 2001). Cy5- and TRITC-conjugated secondary antibodies were purchased from Jackson ImmunoResearch Laboratories. Rhodamine-phalloidin (Molecular Probes) was used to stain F-actin (Eugene); purified human fibrinogen was obtained from Enzyme Research Laboratories, Inc.; coelenterazine (Deep Blue C) was obtained from PerkinElmer; Src inhibitors PP2 and SU6656 were obtained from Calbiochem; and other reagents were obtained from Sigma-Aldrich.
Construction of recombinant proteins
For BRET assays, plasmid templates encoding human IIb, Syk, or mouse c-Src were amplified by PCR to place appropriate restriction sites, and PCR products were subcloned into pGFPN2 and pRlucN2 mammalian expression vectors (Buensuceso et al., 2003) to produce the BRET chimeras in Fig. 1 A. For BiFC assays, plasmid templates encoding human IIb, Syk, mouse c-Src, or the NH2-terminal (YN) or COOH-terminal (YC) halves of YFP (a gift from T. Kerppola and C.-D. Hu, University of Michigan, Ann Arbor, MI; Hu et al., 2002) were amplified to place appropriate restriction sites, and PCR products were subcloned into pCDNA3 to produce the BiFC chimeras in Fig. 2 A. All coding sequences were verified by DNA sequencing, and expression plasmids were purified with the Qiafilter plasmid maxi kit (QIAGEN).
Cell culture and transfections
CHO cells were transiently transfected (Obergfell et al., 2001) with ß3 and the appropriate BRET or BiFC chimeras. In experiments where interactions between two tyrosine kinases were being studied, the tyrosine kinase chimeras were transfected into A5 CHO cells stably expressing IIbß3 or IIbß3724 (Obergfell et al., 2001).
BRET assays
48 h after transfection of BRET chimeras, CHO cells were resuspended to 3 x 106/ml in BRET buffer (Buensuceso et al., 2003), and 30 µl aliquots were added to microtiter wells precoated with 250 µg/µl fibrinogen or 5 mg/ml BSA . After 45 min at RT, 50 µl of luciferase substrate (coelenterazine, 10 µM final concentration) were added and BRET was determined by luminometry using a 410 nm/80 nm bandpass filter for Rluc and a 515 nm/30 nm bandpass filter for GFP. Results are expressed as the BRET ratio calculated as follows: (Emission at 515 nm – BG515)/(Emission at 410 nm – BG410), where BG515 is the emission at 515 nm and BG410 is the emission at 410 nm of a 5-µM solution of coelenterazine prepared in BRET buffer (Xu et al., 1999; Buensuceso et al., 2003).
BiFC assays
48 h after transfection of BiFC chimeras, CHO cells were resuspended in Tyrode's buffer supplemented with 2 mM MgCl2 and CaCl2 and plated for 2 h at 30°C on coverslips precoated with 100 µg/ml fibrinogen to allow cell spreading and maturation of the YFP fluorophore (Hu et al., 2002). In parallel, cells were plated on 5 mg/ml BSA and maintained in suspension. Cells were fixed in 3% formaldehyde, permeabilized with 0.1% Triton X-100, and stained with primary and secondary antibodies. Fluorescence images were acquired with a laser scanning confocal microscope (model MRC 1024; Bio-Rad Laboratories) and processed with imaging software (ISee Imaging Systems). Colocalization of BiFC fluorescence with other fluorescence images was quantified at the single pixel level, and data were accumulated for at least 20 cells over three experiments. In accordance with current definitions, a focal complex was defined here as a round, integrin-based structure smaller than 1 µm2, located 0–3 µm from the leading edge of a migrating cell, whereas a focal adhesion was defined as an elongated, integrin-based structure of 2–3 µm2 linked to actin stress fibers that could be located throughout the basal surface of the cell (Burridge et al., 1988; Jockusch et al., 1995). To monitor BiFC in real time (Kiosses et al., 1999), cells were plated on fibrinogen for 90 min at 30°C. Images were captured using an inverted fluorescence microscope (model TE300; Nikon) equipped with a CCD camera (Model Micromax 1024B ; Roper Scientific) and analyzed with ISEE imaging software.
Online supplemental material
Video 1 shows interactions between IIbß3 and c-Src. This Quicktime movie shows a BiFC signal in real time between IIbYCß3 and c-SrcYN in a CHO cell starting 90 min after plating on fibrinogen. Fluorescence images were acquired at 1-min intervals (1 frame/min) for 34 min as described in Materials and methods. The movie is repeated a second time zooming in on a region of growing lamellipodium and shows the BIFC signal at the cell periphery moving inward to focal complexes and adhesions.
Video 2 shows interactions between c-Src and Syk. This Quicktime movie shows a BiFC signal in real time between c-SrcYN and SykYC in a CHO cell starting 90 min after plating on fibrinogen. Fluorescence images were acquired at 1-min intervals (1 frame/min) for 54 min. The movie is repeated three times over a 9-min period zooming in on a region of growing lamellipodium that shows the BiFC signal at the cell periphery moving inward and reappearing always first at the cell edge. Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.200402064/DC1.
|
Acknowledgments |
|---|
This work was supported by grants from the National Institutes of Health.
Submitted: 11 February 2004
Accepted: 22 March 2004
|
References |
|---|
|
TopAbstractIntroductionResults and discussionMaterials and methodsReferences |
|---|
Alahari, S.K., P.J. Reddig, and R.L. Juliano. 2002. Biological aspects of signal transduction by cell adhesion receptors. Int. Rev. Cytol. 220:145–184.[Medline]
Angers, S., A. Salahpour, E. Joly, S. Hilairet, D. Chelsky, M. Dennis, and M. Bouvier. 2000. Detection of ß2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc. Natl. Acad. Sci. USA. 97:3684–3689.
Arias-Salgado, E.G., S. Lizano, S. Sarker, J.S. Brugge, M.H. Ginsberg, and S.J. Shattil. 2003. Src kinase activation by a novel and direct interaction with the integrin ß cytoplasmic domain. Proc. Natl. Acad. Sci. USA. 100:13298–13302.
Blake, R.A., M.A. Broome, X. Liu, J. Wu, M. Gishizky, L. Sun, and S.A. Courtneidge. 2000. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell. Biol. 20:9018–9027.
Boute, N., R. Jockers, and T. Issad. 2002. The use of resonance energy transfer in high-throughput screening: BRET versus FRET. Trends Pharmacol. Sci. 23:351–354.[CrossRef][Medline]
Buensuceso, C., M. De Virgilio, and S.J. Shattil. 2003. Detection of integrin IIbß3 clustering in living cells. J. Biol. Chem. 278:15217–15224.
Burridge, K., K. Fath, T. Kelly, G. Nuckolls, and C. Turner. 1988. Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton. Annu. Rev. Cell Biol. 4:487–525.[CrossRef][Medline]
Clark, E.A., and J.S. Brugge. 1993. Redistribution of activated pp60c-src to integrin-dependent cytoskeletal complexes in thrombin-stimulated platelets. Mol. Cell. Biol. 13:1863–1871.
Clark, E.A., S.J. Shattil, M.H. Ginsberg, J. Bolen, and J.S. Brugge. 1994. Regulation of the protein tyrosine kinase pp72syk by platelet agonists and the integrin IIbß3. J. Biol. Chem. 269:28859–28864.
Gao, J., K. Zoller, M.H. Ginsberg, J.S. Brugge, and S.J. Shattil. 1997. Regulation of the pp72Syk protein tyrosine kinase by platelet integrin IIbß3. EMBO J. 16:6414–6425.[CrossRef][Medline]
Hanke, J.H., J.P. Gardner, R.L. Dow, P.S. Changelian, W.H. Brissette, E.J. Weringer, B.A. Pollok, and P.A. Connelly. 1996. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271:695–701.
Hato, T., N. Pampori, and S.J. Shattil. 1998. Complementary roles for receptor clustering and conformational change in the adhesive and signaling functions of integrin IIbß3. J. Cell Biol. 141:1685–1695.
Hu, C.D., and T.K. Kerppola. 2003. Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis. Nat. Biotechnol. 21:539–545.[CrossRef][Medline]
Hu, C.D., Y. Chinenov, and T.K. Kerppola. 2002. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol. Cell. 9:789–798.[CrossRef][Medline]
Jockusch, B.M., P. Bubeck, K. Giehl, M. Kroemker, J. Moschner, M. Rothkegel, M. Rüdiger, K. Schlüter, G. Stanke, and J. Winkler. 1995. The molecular architecture of focal adhesions. Annu. Rev. Cell Biol. 11:379–416.[CrossRef][Medline]
Kim, M., C.V. Carman, and T.A. Springer. 2003. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science. 301:1720–1725.
Kiosses, W.B., R.H. Daniels, C. Otey, G.M. Bokoch, and M.A. Schwartz. 1999. A role for p21-activated kinase in endothelial cell migration. J. Cell Biol. 147:831–844.
Kraynov, V.S., C. Chamberlain, G.M. Bokoch, M.A. Schwartz, S. Slabaugh, and K.M. Hahn. 2000. Localized Rac activation dynamics visualized in living cells. Science. 290:333–337.
Linder, S., and M. Aepfelbacher. 2003. Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol. 13:376–385.[CrossRef][Medline]
Lipfert, L., B. Haimovich, M.D. Schaller, B.S. Cobb, J.T. Parsons, and J.S. Brugge. 1992. Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J. Cell Biol. 119:905–912.
McHugh, K.P., K. Hodivala-Dilke, M.H. Zheng, N. Namba, J. Lam, D. Novack, X. Feng, F.P. Ross, R.O. Hynes, and S.L. Teitelbaum. 2000. Mice lacking ß3 integrins are osteosclerotic because of dysfunctional osteoclasts. J. Clin. Invest. 105:433–440.[Medline]
Miranti, C., L. Leng, P. Maschberger, J.S. Brugge, and S.J. Shattil. 1998. Integrin-induced assembly of a Syk- and Vav1-regulated signaling pathway independent of actin polymerization. Curr. Biol. 8:1289–1299.[CrossRef][Medline]
Miyamoto, S., H. Teramoto, O.A. Coso, J.S. Gutkind, P.D. Burbelo, S.K. Akiyama, and K.M. Yamada. 1995. Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J. Cell Biol. 131:791–805.
Mukhopadhyay, S., A.S.S. Ramars, and D. Dash. 2001. Bruton's tyrosine kinase associates with the actin-based cytoskeleton in activated platelets. J. Cell. Biochem. 81:659–665.[CrossRef][Medline]
Obergfell, A., B.A. Judd, M.A. del Pozo, M.A. Schwartz, G. Koretzky, and S. Shattil. 2001. The molecular adapter SLP-76 relays signals from platelet integrin IIbß3 to the actin cytoskeleton. J. Biol. Chem. 276:5916–5923.
Obergfell, A., K. Eto, A. Mocsai, C. Buensuceso, S.L. Moores, J.S. Brugge, C.A. Lowell, and S.J. Shattil. 2002. Coordinate interactions of Csk, Src, and Syk kinases with IIbß3 initiate integrin signaling to the cytoskeleton. J. Cell Biol. 157:265–275.
Parsons, J.T. 2003. Focal adhesion kinase: the first ten years. J. Cell Sci. 116:1409–1416.
Ramsay, D., E. Kellett, M. McVey, S. Rees, and G. Milligan. 2002. Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochem. J. 365:429–440.[CrossRef][Medline]
Schaller, M.D., C.A. Otey, J.D. Hildebrand, and J.T. Parsons. 1995. Focal adhesion kinase and paxillin bind to peptides mimicking ß integrin cytoplasmic domains. J. Cell Biol. 130:1181–1187.
Schwartz, M.A. 2001. Integrin signaling revisited. Trends Cell Biol. 11:466–470.[CrossRef][Medline]
Shattil, S.J., H. Kashiwagi, and N. Pampori. 1998. Integrin signaling: the platelet paradigm. Blood. 91:2645–2657.
Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell. 64:693–702.[CrossRef][Medline]
Vinogradova, O., A. Velyvis, A. Velyviene, B. Hu, T. Haas, E. Plow, and J. Qin. 2002. A structural mechanism of integrin IIbß3 "inside-out" activation as regulated by its cytoplasmic face. Cell. 110:587–597.[CrossRef][Medline]
Webb, D.J., C.M. Brown, and A.F. Horwitz. 2003. Illuminating adhesion complexes in migrating cells: moving toward a bright future. Curr. Opin. Cell Biol. 15:614–620.[CrossRef][Medline]
Woodside, D.G., A. Obergfell, L. Leng, J.L. Wilsbacher, C.K. Miranti, J.S. Brugge, S.J. Shattil, and M.H. Ginsberg. 2001. Activation of Syk protein tyrosine kinase mediated by interaction with integrin ß cytoplasmic domains. Curr. Biol. 11:1799–1804.[CrossRef][Medline]
Woodside, D.G., A. Obergfell, A. Talapatra, D.A. Calderwood, S.J. Shattil, and M.H. Ginsberg. 2002. The N-terminal SH2 domains of Syk and ZAP-70 mediate phosphotyrosine-independent binding to integrin ß cytoplasmic domains. J. Biol. Chem. 277:39401–39408.
Xu, Y., D.W. Piston, and C.H. Johnson. 1999. A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. Proc. Natl. Acad. Sci. USA. 96:151–156.
Zamir, E., and B. Geiger. 2001. Molecular complexity and dynamics of cell-matrix adhesions. J. Cell Sci. 114:3583–3590.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
